Legend Biotech Corp. ADR (LEGN) News
Filter LEGN News Items
LEGN News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Latest LEGN News From Around the Web
Below are the latest news stories about LEGEND BIOTECH CORP that investors may wish to consider to help them evaluate LEGN as an investment opportunity.
Q2 2023 Legend Biotech Corp Earnings CallQ2 2023 Legend Biotech Corp Earnings Call |
Legend Biotech Reports Second Quarter 2023 Results and Recent HighlightsSOMERSET, N.J., August 15, 2023--Legend Biotech reported its unaudited financial results for the three and six months ended June 30, 2023. |
Why Earnings Season Could Be Great for Legend Biotech (LEGN)Legend Biotech (LEGN) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season. |
3 Biotech Stocks Poised to Beat Q2 Earnings EstimatesWe look at a few biotech companies, LEGN, KOD, GRTX, which are poised to beat second-quarter earnings estimates. |
Top 5 Stocks Set to Beat on Earnings Next WeekWe have narrowed our search to five stocks that are set to declare earnings results next week. These are: LEGN, TJX, WMT, ONON, BILL. |
3 Biotech Stocks That Analysts Are Drooling OverWith the medical science realm representing one of the most complex markets, these top analyst biotech picks can be worth your time. |
Legend Biotech to Host Investor Conference Call on Second-Quarter ResultsSOMERSET, N.J., August 03, 2023--Legend Biotech will host a call to discuss second-quarter 2023 earnings on August 15, 2023 at 8:00am ET. |
AMD upgraded, Electronic Arts downgraded: Wall Street's top analyst callsAMD upgraded, Electronic Arts downgraded: Wall Street's top analyst calls |
What Makes Legend Biotech Corporation (LEGN) a Unique and Exciting Investment Opportunity?Baron Funds, an investment management company, released its “Baron Health Care Fund” second quarter 2023 investor letter. A copy of the same can be downloaded here. The fund advanced 9.22% (Institutional Shares) in the quarter compared to a 3.44% gain for the Russell 3000 Health Care Index (benchmark) and an 8.74% gain for the S&P 500 […] |
This Top-Performing Small-Cap Manager Is Betting Big on ChinaThe Matthews Emerging Markets Small Companies fund has delivered a 15.1% annualized three-year return, landing it in the top 1% of its peers. Here’s what manager Vivek Tanneeru is buying now. |